Recent Headlines
Within Biotechnology
Parvus Therapeutics Announces CEO, Senior Executive, and Board of Directors Appointments
Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.
Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Pepex Biomedical Receives Approval on a Series of Critical New Patents
Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. - July 01, 2021 - Pepex Biomedical, Inc.
GRG Announces 2021 Regenerative Medicine Congress in Dubai UAE
The 2nd Global Regenerative Medicine Congress will be held in Dubai 9-11 September 2021. Registration is now open. Global Regenerative Academy is a world-renowned medical society scientifically studying the clinical application of biological products in the human body. Regenerative Medicine treatments using biological products have been used to slow down the natural aging process, treat a variety of pathologies and improve the quality of life of patients. - June 28, 2021 - Global Regenerative Group
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model
Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals
Locus Performance Ingredients Launches Amphi™ M: The Next Generation of Biosurfactants for Household and Industrial Formulations
TSCA-approved sophorolipid is customized to offer safe, green replacements to legacy surfactants with unmatched efficacy. - June 11, 2021 - Locus Performance Ingredients
Canada’s Leader in Cannabis Genetics Enters Medical Market
Apollo Green, Canada’s leader in cannabis genetics, announced its entry into the medical marijuana sales with unique strains of cannabis not commonly available in the Canadian marketplace. The importance of having available alternatives for pain management cannot be understated. Studies have recently shown the link between cannabis availability and reduced use of opioids. Three specialty strains of plants and seven strains of seeds will be available in Ontario, Canada. - June 08, 2021 - Apollo Green
Thrivous Launches Omega Cardioprotector Formula 2
Thrivous, the human enhancement company, has released Omega Cardioprotector Formula 2. Omega is an advanced geroprotector supplement that Thrivous develops to enhance heart function and circulation for better aging. Omega formula 2 combines geroprotector nutrients with the highest levels of... - June 03, 2021 - Thrivous
ALS TDI Launches New Young Faces of ALS Program
The ALS Therapy Development Institute's Young Faces of ALS program spreads awareness about the impact that ALS can have on young people; launch coincides with MLB's inaugural Lou Gehrig Day. - June 02, 2021 - ALS Therapy Development Institute
ICIS Names Locus Performance Ingredients Top Newcomer in the World Surfactants Awards for Biosurfactant Innovations
Company is praised for proprietary fermentation technology that produces high-purity, zero-carbon sophorolipids with maximized performance and sustainability. - May 27, 2021 - Locus Performance Ingredients
Solaris Chem Expands Its Distributors Network
Solaris Chem is a company working in the field of fine organic chemistry, synthesizing materials for the organic electronic industry since 2007. His R&D program is mainly focused on the synthesis of custom made semi-conducting polymers, fullerene derivatives and dyes specially formulated for... - May 26, 2021 - Solaris Chem Inc.
Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
eCTD Solutions Appoints New CEO and Changes Name to Highlight Expanded Capability
Sunny Ayr Holdings, a group of healthcare product solutions companies, is pleased to announce the change of the name of eCTD Solutions Ltd. to Omni Early Development Services and the appointment of Mark Marino, MD as Partner and Chief Executive Officer of the early product development solutions provider. - May 19, 2021 - Sunny Ayr Holdings
Healthy Cow Accepted to the Award-Winning THRIVE Accelerator Program
Healthy Cow Corporation has officially been selected to join the SVG THRIVE accelerator program from a pool of nearly 700 agtech startup applications worldwide. - May 19, 2021 - Healthy Cow
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group
Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection
Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company
CNS Healthcare Announces Launch of eReg Platform, Making Access to Regulatory Documents Available from Virtually Anywhere at Any Time
CNS Healthcare announced today the launch of eReg, an electronic regulatory binder platform. This first of its kind, web-based application will essentially replace paper binders and allow for remote monitoring capability. The proprietary platform developed by CNS Healthcare CIO & CISO, Florin... - May 14, 2021 - CNS Healthcare
Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021
Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy
USDA BioPreferred Program Certifies Locus Performance Ingredients Biosurfactants as 100% Biobased
Formulators can use Ferma™ S or Amphi™ M renewable sophorolipids as sustainable, high-performance alternatives to chemical surfactants in CPG formulations. - April 24, 2021 - Locus Performance Ingredients
Courage Therapeutics Awarded STTR Grant to Design Novel Anorexia Drugs
Courage Therapeutics has been awarded an STTR grant by the National Insittute of Mental Health to design novel anorexia drugs. The grant is a follow-up to research by the Cone lab at the University of Michigan that recently published in Science Translational Research that MC3R is a potential target for therapeutic development in anorexia and obesity. The effort allows for an expeditious translation of basic science into eating disorders which have remained an area of significant unmet need. - April 23, 2021 - Courage Therapeutics
Temperatures Are Rising – It's Time to Check Your Cooling Towers
As Texas and other parts of the country start to heat up, cooling towers will be in full use. Hyperion Biotechnology offers Legionella testing to monitor for bacteria growth to help reduce the risk of spread from cooling towers. - April 21, 2021 - Hyperion Biotechnology, Inc.
Adexilis Adria Opened
Adexilis Adria is the latest company established within the Adexilis network. Adexilis Adria covers the markets Croatia, Slovenia, Serbia, Bosnia Herzegovina, and Macedonia. The initial focus and products will be in Gastroenterology and Women's Health. The aim is to search for cutting edge... - April 17, 2021 - Adexilis Schweiz AG
Y-Biologics & Pierre Fabre: Confirmation of Research Partnership in Oncology
Y-Biologics and Pierre Fabre confirm their research collaboration for the development of new immunotherapies in oncology. - March 31, 2021 - Pierre Fabre
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders
Courage Therapeutics raised $1M towards development of treatments for eating disorders including Anorexia Nervosa, ARFID, BED and genetic obesity. The company is led by Dan Housman a parent of children with eating disorders. The round was led by Michigan Biomedical Ventures. Funding will be used to test Courage’s proprietary compounds in animal models of eating disorders. The technology is based on the research on MC3R at the University of Michigan from co-founder Dr. Roger Cone’s lab. - March 24, 2021 - Courage Therapeutics
AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
Zifo RnD Solutions Bags the Fastest Growing Company Award at Deloitte Technology Fast 50 2020
Zifo RnD Solutions has been featuring in this list since 2012 and is the only company in India to have won this award 9 years in a row. - March 15, 2021 - Zifo
Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development
Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021 - Eurofins Viracor BioPharma
Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations
Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021 - Intrinsic Imaging, LLC
AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
Stargardt Disease - MD Stem Cells New Treatment Improves Vision
Stem Cell Ophthalmology Treatment Study (SCOTS) show positive results in 84% of eyes. - February 18, 2021 - MD Stem Cells
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
Phase One Development of Rapid COVID-19 Point of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.
Collection Services Provide Peace of Mind in Fight Against Legionella Bacteria
Hyperion Biotechnology expands Legionella water collection services in several California cities and other U.S. locations. Facility owners can schedule services to support their water safety plans. - February 11, 2021 - Hyperion Biotechnology, Inc.
Cayman Adds Nordic BioSite as Trusted Distributor
Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company
Kevin Sarney Joins Charles River CFO to Lead Life Sciences Practice
Charles River CFO, Inc. (CRCFO), a provider of part-time and interim CFO and accounting services, today announced Kevin Sarney has joined the leadership team as the Life Sciences Practice Leader and CFO. With over 20 years of experience in public and private life sciences companies, Kevin will lead... - January 21, 2021 - Charles River CFO
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics
14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.
Leading the "Bio-Chem Renaissance": Top CPG Companies Drive Demand for Green Biosurfactant Ingredients
Supplier Locus Performance Ingredients doubles production capacity to meet growing interest for cleaner product formulations. - January 01, 2021 - Locus Performance Ingredients
A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions
Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology
NuvOx Pharma Announces Appointment of Jon S. Saxe to Its Board of Directors
NuvOx Pharma today announced that Jon S. Saxe has joined its Board of Directors. Saxe brings to NuvOx many years of experience from the biotechnology, pharmaceutical and venture capital industries. He has served as a director of more than 25 companies and currently is a director of several... - December 28, 2020 - NuvOx Pharma
GRG Announces Partnership with BPB Medica
The Global Regenerative Group and BPB Medica(TM) Italy are very pleased to announce a global consultancy relationship to further develop the distribution of BPB Medica(TM) products. - December 02, 2020 - Global Regenerative Group
Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient
Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO
New Rapid COVID-19 Point of Care Test
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.
Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D
Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company
3 Steps to Take Now to Reduce the Risk of Legionella in a Building’s Water System
After shutdowns due to coronavirus, businesses are reopening and there are steps building owners can take to check the water safety of their buildings. Hyperion provides Legionella water testing to help businesses reduce the risk of Legionella. - November 01, 2020 - Hyperion Biotechnology, Inc.
Adeoye Olukotun, M.D., MPH, FACC Joins Evon Medics, LLC as Advisor
Small business, Evon Medics, LLC today announced that pharmaceutical luminary and cardiologist, Dr. Adeoye Olukotun has joined the advisory board of the company in a formal advisory role. Dr. Olukotun is currently the Chief Executive Officer of CR Strategies, LLC, which consults on clinical trial... - November 01, 2020 - Evon Medics, LLC
Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to volasertib for its use in treating pediatric rhabdomyosarcoma and other rare soft tissue sarcomas. Key... - October 15, 2020 - Oncoheroes Biosciences Inc.
3Sixty Pharma Solutions Announces Successful Approval of FDA Investigational New Drug Application
3Sixty Pharma Solutions LLC., www.3sixtypharma.com, has announced the successful submission to FDA, and approval of, an Investigational New Drug (IND) Application on behalf of one of its clinical-stage biotech clients. 3Sixty Pharma Solutions’ 360 Start-Up arm continues to be committed to... - October 15, 2020 - 3Sixty Pharma Solutions